Anzeige
Mehr »
Montag, 24.11.2025 - Börsentäglich über 12.000 News
Amerikas Rohstoff-Zukunft - Jetzt beginnt das strategische Kupfer-Investment!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DSFQ | ISIN: JE00BPG99318 | Ticker-Symbol:
NASDAQ
21.11.25 | 21:59
3,070 US-Dollar
+18,08 % +0,470
Branche
Kosmetik
Aktienmarkt
Sonstige
1-Jahres-Chart
WALDENCAST PLC Chart 1 Jahr
5-Tage-Chart
WALDENCAST PLC 5-Tage-Chart

Aktuelle News zur WALDENCAST Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.11.Waldencast plc: Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting1
14.11.Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities931NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today announced that it had sold its...
► Artikel lesen
14.11.Waldencast plc - 6-K, Report of foreign issuer-
12.11.Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates1
WALDENCAST Aktie jetzt für 0€ handeln
08.10.Waldencast plc: Obagi Medical Launches Nu-Cil BioStim Scalp Serum1
10.09.Waldencast Says Obagi Saypha MagIQ Injectable Hyaluronic Acid Gel Approved In U.S.-
10.09.Waldencast plc - 6-K, Report of foreign issuer1
10.09.Waldencast plc: Waldencast Announces FDA Approval of Obagi saypha MagIQ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand898LONDON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration ("FDA") has...
► Artikel lesen
20.08.Waldencast Delays Earnings Release, Launches Strategic Review4
20.08.Waldencast Reports H1 2025 Brand Growth, Acquires Novaestiq, and Reviews Strategic Options2
18.08.Waldencast plc: Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation1.045Obagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand's Addressable Market in the U.S. Milk Makeup Delivers Strong Retail Sales...
► Artikel lesen
18.08.Waldencast plc - 6-K, Report of foreign issuer2
18.08.Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts3
25.07.Waldencast Doubles Down on Aesthetics with Novaestiq Acquisition and U.S. Rights to Saypha Injectable Line1
23.07.Croma Pharma: Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast946Saypha® injectables to launch in the U.S. under the Obagi Medical brand, expanding global reach of Croma's science-driven aesthetic solutions LEOBENDORF, Austria, July 23, 2025 /PRNewswire/...
► Artikel lesen
23.07.Waldencast expandiert durch Übernahme von Novaestiq in den Markt für Injektionsmittel4
23.07.Waldencast acquires Novaestiq to expand Obagi Medical into injectables2
23.07.Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast705Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio SOUTHLAKE, TX / ACCESS Newswire / July 23, 2025 / Gore Range Capital (GRC) announced...
► Artikel lesen
23.07.Waldencast plc - 6-K, Report of foreign issuer1
23.07.Waldencast plc: Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha, Under the Obagi Medical Brand596Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi Medical at the forefront of health, beauty and aesthetics...
► Artikel lesen
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1